Bionano Genomics, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $9.5M |
| Cost of Revenue | $6.0M |
| Gross Profit | $3.5M |
| Gross Margin | 36.6% |
| Operating Expenses | |
| Research & Development | $12.0M |
| SG&A Expense | $14.1M |
| Operating Income | $-23.2M |
| Operating Margin | -244.3% |
| Interest Expense | $590.9K |
| Pretax Income | $-23.3M |
| Income Tax Expense | $18.6K |
| Net Income | $-23.4M |
| Net Margin | -245.8% |
| EPS (Basic) | $-1.08 |
| EPS (Diluted) | $-1.08 |
| Shares Outstanding (Basic) | 618.1K |
| Shares Outstanding (Diluted) | 618.1K |
| Dividends Per Share | — |